サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451706

DNAメチル化市場レポート：製品、技術、用途、エンドユーザー、地域別、2024-2032

DNA Methylation Market Report by Product, Technology (Polymerase Chain Reaction, Microarray, Sequencing, and Others), Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 148 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
DNAメチル化市場レポート：製品、技術、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のDNAメチル化市場規模は2023年に14億米ドルに達しました。今後、IMARC Groupは、市場が2032年までに45億米ドルに達し、2024年から2032年の間に13.5%の成長率（CAGR）を示すと予測しています。同市場は、エピジェネティック研究における継続的な技術的進歩、疾患診断におけるメチル化バイオマーカー同定の重要性の高まり、精密医療における製品アプリケーションの大幅な成長によって、着実な成長を遂げています。

DNAメチル化市場の分析

市場の成長と規模：世界市場は、疾患メカニズムの解明、精密医療の進展、潜在的な治療標的の同定におけるエピジェネティック研究の採用増加により、力強い成長を遂げています。研究者や産業界がDNAメチル化解析の極めて重要な役割を認識するにつれて、市場規模は拡大し、診断、医薬品、学術研究など多様な分野のアプリケーションを包含しています。

主な市場促進要因：主な促進要因としては、個別化医療に対する需要の高まり、疾患診断のためのDNAメチル化バイオマーカーの同定、創薬におけるエピジェネティックな知見の統合などが挙げられます。さらに、慢性疾患の有病率の増加や高度な診断ツールの必要性が市場成長に寄与しています。

技術の進歩：ハイスループットシーケンス技術、マイクロアレイプラットフォーム、データ解析ソフトウェアの継続的な進歩により、DNAメチル化解析の効率と精度が向上しています。このような進歩により、研究者は複雑なエピジェネティック・ランドスケープを探索することが可能になり、DNAメチル化パターンと健康および疾患におけるその意味するところをより深く理解することに貢献しています。

産業への応用本製品は、臨床診断、製薬、バイオテクノロジー研究、学術研究など、さまざまな業界で幅広く応用されています。DNAメチル化解析は、疾患検出、バイオマーカー探索、薬剤開発のための貴重なツールとして機能し、ヘルスケア、ライフサイエンス、生物医学研究の多様な側面への統合を促進します。

主な市場動向：主な動向には、シーケンス技術の優位性、遺伝子治療における革新的アプリケーションの出現、精密医療の重視の高まりなどがあります。市場は、包括的なゲノムワイド解析へのシフトを目の当たりにしており、研究者は複雑なエピジェネティックメカニズムを解明し、新規治療ターゲットを特定することができます。

地理的動向：地理的には、北米が市場をリードしており、先進的なヘルスケアインフラ、大規模な研究投資、ゲノム研究への注力などがその要因となっています。アジア太平洋地域は、ヘルスケアへの取り組みの増加や個別化医療に対する意識の高まりに後押しされ、顕著な成長を遂げています。欧州は、DNAメチル化解析の進歩のために確立された研究インフラと共同研究を活用しており、依然として重要なプレーヤーです。

競合情勢：競合情勢の特徴は、主要企業が研究開発に多額の投資を行っていることです。各社は競争力を維持するため、革新的技術の開発、製品ポートフォリオの拡充、戦略的提携に注力しています。市場には既存プレーヤーと新規参入プレーヤーが混在しており、状況の変化に貢献しています。

課題と機会：課題には、大規模エピゲノムデータ解析の複雑さ、標準化されたプロトコルの必要性、エピジェネティック情報の利用における倫理的配慮などが含まれます。しかし、これらの課題は、技術の進歩、標準化の取り組み、倫理的ガイドラインの開拓などの機会をもたらし、市場の成長をさらに促進する可能性があります。

将来の展望：市場の将来は有望であり、持続的な成長が見込まれます。技術の継続的な進歩、精密医療への応用の拡大、エピジェネティック・ランドスケープの絶え間ない探求が、市場を前進させると予想されます。課題は協力的な取り組みを通じて解決され、イノベーションが促進され、多様な業界にわたるDNAメチル化解析の統合の機会が拡大します。

DNAメチル化市場の動向：

エピジェネティック研究の進展

エピジェネティック研究の継続的な進歩により、市場は大きな成長を遂げています。遺伝子発現、細胞分化、研究開発など、さまざまな生物学的プロセスにおける複雑な制御メカニズムとその影響について、研究者やバイオテクノロジストによる解明が進んでいます。次世代シークエンシングやハイスループットメチル化アッセイなどの最先端技術が利用可能になったことで、これらのメチル化パターンをゲノム規模で包括的に解析することが容易になった。エピゲノムの理解が進むにつれて、高度なメチル化解析ツールやサービスへの需要が高まり、市場の成長を牽引しています。

疾患診断におけるメチル化バイオマーカー同定の重要性の高まり

DNAメチル化は遺伝子発現の制御において重要な役割を果たしており、がんを含む様々な疾患の発症と進行に複雑に関与しています。これらのメチル化バイオマーカーの同定は、疾患の診断、予後、治療の意思決定に重要な役割を果たしています。市場は、これらのメチル化シグネチャーが疾患状態の貴重な指標であるとの認識が高まっていることに後押しされています。研究者や臨床医は、このメチル化解析を活用して、早期発見、治療反応のモニタリング、個別化治療介入の開発のための新規バイオマーカーを発見し、市場の拡大を促進しています。

精密医療における応用の拡大

患者固有の遺伝的およびエピジェネティックなプロファイルに基づいて個々の患者に合わせた精密医療アプローチの採用は、市場の主要な促進要因です。DNAメチル化パターンは、疾患感受性、治療反応、患者の転帰に影響を及ぼす必須エピジェネティックマーカーとして機能します。ヘルスケアにおいて精密医療が注目されるにつれ、メチル化解析は患者固有のエピゲノム変異を特徴付けるために不可欠なものとなっています。この応用は、腫瘍学にとどまらず、神経変性疾患や心血管疾患など、さまざまな疾患に広がっています。個別化された治療戦略が患者の転帰を大幅に改善できるという認識の高まりが、このメチル化プロファイリングへの需要を煽り、精密医療における変化の最前線に市場を位置づけています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界のDNAメチル化市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 消耗品
    • 市場動向
    • 市場予測
  • キット・試薬
    • 市場動向
    • 市場予測
  • 酵素
    • 市場動向
    • 市場予測
  • 機器とソフトウェア
    • 市場動向
    • 市場予測

第7章 市場内訳：技術別

  • ポリメラーゼ連鎖反応（PCR）
    • 市場動向
    • 市場予測
  • マイクロアレイ
    • 市場動向
    • 市場予測
  • シーケンシング
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 遺伝子治療
    • 市場動向
    • 市場予測
  • 臨床研究
    • 市場動向
    • 市場予測
  • 診断
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院・診断研究所
    • 市場動向
    • 市場予測
  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • 研究・学術機関
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abcam plc.
    • Active Motif Inc.
    • Diagenode S.A.（Hologic Inc.）
    • EpiGentek Group Inc.
    • Illumina Inc.
    • Merck KGaA
    • New England Biolabs Inc.
    • PerkinElmer Inc.
    • Qiagen N.V.
    • Thermo-Fisher Scientific Inc.
    • Zymo Research Corporation
図表

List of Figures

  • Figure 1: Global: DNA Methylation Market: Major Drivers and Challenges
  • Figure 2: Global: DNA Methylation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: DNA Methylation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: DNA Methylation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: DNA Methylation Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: DNA Methylation Market: Breakup by Application (in %), 2023
  • Figure 7: Global: DNA Methylation Market: Breakup by End User (in %), 2023
  • Figure 8: Global: DNA Methylation Market: Breakup by Region (in %), 2023
  • Figure 9: Global: DNA Methylation (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: DNA Methylation (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: DNA Methylation (Kits and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: DNA Methylation (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: DNA Methylation (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: DNA Methylation (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: DNA Methylation (Instrument and Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: DNA Methylation (Instrument and Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: DNA Methylation (Polymerase Chain Reaction (PCR)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: DNA Methylation (Polymerase Chain Reaction (PCR)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: DNA Methylation (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: DNA Methylation (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: DNA Methylation (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: DNA Methylation (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: DNA Methylation (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: DNA Methylation (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: DNA Methylation (Gene Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: DNA Methylation (Gene Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: DNA Methylation (Clinical Research) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: DNA Methylation (Clinical Research) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: DNA Methylation (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: DNA Methylation (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: DNA Methylation (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: DNA Methylation (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: DNA Methylation (Hospital and Diagnostic Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: DNA Methylation (Hospital and Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: DNA Methylation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: DNA Methylation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: DNA Methylation (Research and Academia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: DNA Methylation (Research and Academia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: DNA Methylation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: DNA Methylation Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: DNA Methylation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: DNA Methylation Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: DNA Methylation Industry: Value Chain Analysis
  • Figure 90: Global: DNA Methylation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: DNA Methylation Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: DNA Methylation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: DNA Methylation Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: DNA Methylation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: DNA Methylation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: DNA Methylation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: DNA Methylation Market: Competitive Structure
  • Table 8: Global: DNA Methylation Market: Key Players
目次
Product Code: SR112024A6890

The global DNA methylation market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.5% during 2024-2032. The market is experiencing steady growth driven by the continual technological advancements in epigenetic research, the rising significance of methylation biomarker identification in disease diagnosis, and the considerable growth in product applications in precision medicine.

DNA Methylation Market Analysis:

Market Growth and Size: The global market is experiencing robust growth, driven by the increasing adoption of epigenetic research in understanding disease mechanisms, advancing precision medicine, and identifying potential therapeutic targets. As researchers and industries recognize the pivotal role of DNA methylation analysis, the market is expanding in size, encompassing applications across diverse sectors such as diagnostics, pharmaceuticals, and academic research.

Major Market Drivers: Key drivers include the rising demand for personalized medicine, the identification of DNA methylation biomarkers for disease diagnosis, and the integration of epigenetic insights in drug discovery. Additionally, the increasing prevalence of chronic diseases and the need for advanced diagnostic tools contribute to the market growth.

Technological Advancements: Continuous progress in high-throughput sequencing technologies, microarray platforms, and data analysis software enhances the efficiency and accuracy of DNA methylation analysis. These advancements enable researchers to explore the intricate epigenetic landscape, contributing to a deeper understanding of DNA methylation patterns and their implications in health and disease.

Industry Applications: The product finds extensive applications in various industries, including clinical diagnostics, pharmaceutical and biotechnology research, and academic studies. DNA methylation analysis serves as a valuable tool for disease detection, biomarker discovery, and drug development, fostering its integration into diverse facets of healthcare, life sciences, and biomedical research.

Key Market Trends: Key trends include the dominance of sequencing technologies, the emergence of innovative applications in gene therapy, and the growing emphasis on precision medicine. The market is witnessing a shift towards comprehensive genome-wide analysis, enabling researchers to unravel complex epigenetic mechanisms and identify novel therapeutic targets.

Geographical Trends: Geographically, North America leads the market, driven by advanced healthcare infrastructure, significant research investments, and a focus on genomic research. The Asia-Pacific region is witnessing notable growth, propelled by increasing healthcare initiatives and a rising awareness of personalized medicine. Europe remains a significant player, leveraging well-established research infrastructure and collaborations for advancements in DNA methylation analysis.

Competitive Landscape: The competitive landscape is characterized by key players investing heavily in research and development. Companies are focusing on developing innovative technologies, expanding their product portfolios, and forming strategic collaborations to maintain a competitive edge. The market showcases a mix of established players and emerging entrants, contributing to a changing landscape.

Challenges and Opportunities: Challenges include the complexity of analyzing large-scale epigenomic data, the need for standardized protocols, and ethical considerations in the use of epigenetic information. However, these challenges present opportunities for technological advancements, standardization efforts, and the development of ethical guidelines, which can further propel the market's growth.

Future Outlook: The future of the market appears promising, with sustained growth anticipated. Ongoing advancements in technology, increasing applications in precision medicine, and the continuous exploration of epigenetic landscapes are expected to drive the market forward. Challenges will be addressed through collaborative efforts, fostering innovation and expanding opportunities for the integration of DNA methylation analysis across diverse industries.

DNA Methylation Market Trends:

Advancements in epigenetic research

The market is experiencing significant growth due to continuous advancements in epigenetic research. Researchers and biotechnologists are increasingly unraveling the complex regulatory mechanisms and its implications in various biological processes, including gene expression, cellular differentiation, and disease development. The availability of cutting-edge technologies, such as next-generation sequencing and high-throughput methylation assays, facilitates comprehensive analysis of these methylation patterns at a genome-wide scale. As our understanding of the epigenome expands, the demand for advanced methylation analysis tools and services rises, driving the growth of the market.

Rising significance of methylation biomarker identification in disease diagnosis

DNA methylation plays a crucial role in the regulation of gene expression and is intricately involved in the development and progression of various diseases, including cancer. The identification of these methylation biomarkers has become instrumental in disease diagnosis, prognosis, and therapeutic decision-making. The market is propelled by the increasing recognition of these methylation signatures as valuable indicators of disease states. Researchers and clinicians are leveraging this methylation analysis to discover novel biomarkers for early detection, monitoring treatment responses, and developing personalized therapeutic interventions, thereby fostering the market's expansion.

Growing applications in precision medicine

The adoption of precision medicine approaches, tailored to individual patients based on their unique genetic and epigenetic profiles, is a key driver for the market. DNA methylation patterns serve as essential epigenetic markers that influence disease susceptibility, treatment responses, and patient outcomes. As precision medicine gains prominence in healthcare, methylation analysis becomes integral for characterizing patient-specific epigenomic variations. This application extends beyond oncology to various diseases, including neurodegenerative disorders and cardiovascular conditions. The growing realization that personalized therapeutic strategies can significantly improve patient outcomes fuels the demand for this methylation profiling, positioning the market at the forefront of the changing landscape in precision medicine.

DNA Methylation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, technology, application, and end user.

Breakup by Product:

Consumables

Kits and Reagents

Enzymes

Instrument and Software

Consumables account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, kits and reagents, enzymes, and instrument and software. According to the report, consumables represented the largest segment.

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Microarray

Sequencing

Others

Sequencing holds the largest share of the industry

A detailed breakup and analysis of the market based on the technology have also been provided in the report. This includes polymerase chain reaction (PCR), microarray, sequencing, and others. According to the report, sequencing accounted for the largest market share.

Breakup by Application:

Gene Therapy

Clinical Research

Diagnostics

Others

Clinical research represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes gene therapy, clinical research, diagnostics, and others. According to the report, clinical research represented the largest segment.

Breakup by End User:

Hospital and Diagnostic Laboratories

Pharmaceutical and Biotechnology Companies

Research and Academia

Pharmaceutical and biotechnology companies represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital and diagnostic laboratories, pharmaceutical and biotechnology companies, and research and academia. According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest DNA methylation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abcam plc.

Active Motif Inc.

Diagenode S.A. (Hologic Inc.)

EpiGentek Group Inc.

Illumina Inc.

Merck KGaA

New England Biolabs Inc.

PerkinElmer Inc.

Qiagen N.V.

Thermo-Fisher Scientific Inc.

Zymo Research Corporation

Key Questions Answered in This Report:

  • How has the global DNA methylation market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global DNA methylation market?
  • What is the impact of each driver, restraint, and opportunity on the global DNA methylation market?
  • What are the key regional markets?
  • Which countries represent the most attractive DNA methylation market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the DNA methylation market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the DNA methylation market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the DNA methylation market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the DNA methylation market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global DNA methylation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global DNA Methylation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Kits and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Enzymes
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Instrument and Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microarray
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Gene Therapy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinical Research
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital and Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Pharmaceutical and Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research and Academia
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abcam plc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Active Motif Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Diagenode S.A. (Hologic Inc.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 EpiGentek Group Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Illumina Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Merck KGaA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 New England Biolabs Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 PerkinElmer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Qiagen N.V.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo-Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Zymo Research Corporation
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.